CPL - Chalmers Publication Library
| Utbildning | Forskning | Styrkeområden | Om Chalmers | In English In English Ej inloggad.

Improving the economics of NASH/NAFLD treatment through the use of systems biology

J. Bosley ; C. Boren ; S. Lee ; Morten Grøtli ; Jens B. Nielsen (Institutionen för biologi och bioteknik, Systembiologi) ; M. Uhlen ; Jan Borén ; Adil Mardinoglu (Institutionen för biologi och bioteknik, Systembiologi)
Drug Discovery Today (1359-6446). Vol. 22 (2017), 10, p. 1532-1538.
[Artikel, refereegranskad vetenskaplig]

Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD). We surveyed NASH therapies currently in development, and found a significant variety of targets and approaches. Evaluation and clinical testing of these targets is an expensive and time-consuming process. Systems biology approaches could enable the quantitative evaluation of the likely efficacy and safety of different targets. This motivated our review of recent systems biology studies that focus on the identification of targets and development of effective treatments for NASH. We discuss the potential broader use of genome-scale metabolic models and integrated networks in the validation of drug targets, which could facilitate more productive and efficient drug development decisions for the treatment of NASH.

Denna post skapades 2017-11-17.
CPL Pubid: 253230


Läs direkt!

Länk till annan sajt (kan kräva inloggning)

Institutioner (Chalmers)

Institutionen för biologi och bioteknik, Systembiologi


Farmakologi och toxikologi

Chalmers infrastruktur